Aristotle University Of Thessaloniki (AUTH)
Σχέση των επιπέδων της καρνιτίνης και των προϊόντων του ενδιάμεσου μεταβολισμού του νεογνού με τα επίπεδα καρνιτίνης της μητέρας σε φυσιολογική και διαβητική κύηση
Abstract
dc:descriptionCarnitine (β-hydroxy-γ-trimethylaminobutyric acid) is an essential cofactor for the transport of long-chain fatty acids across the inner mitochondrial membrane into the mitochondrial matrix, where they are oxidized via β-oxidation. In addition, it is an important regulator in carbohydrate and amino acid metabolism and also buffers potentially toxic acylcoenzyme A (acyl-CoA) metabolites. The sufficiency of free carnitine (FC) and a stable equilibrium between FC and acylcarnitine (AC) are crucial in maintaining adequate carnitine shuttle function. The low carnitine levels in pregnancy reported in previous studies raise concerns regarding the consequences they might have for the mother and the fetus/neonate, especially in pregnancies complicated with gestational diabetes. Theoretically, gestational diabetes is an additional risk factor for carnitine insufficiency in pregnancy, since previous studies showed decreased levels of FC in patients with diabetes mellitus. Furthermore, there is no data on the impact of gestational diabetes on the carnitine shuttle of the fetus/neonate, which depends on the carnitine transfer via the placenta. So far, there is only one published study on carnitine levels in the diabetic pregnant women, which reported increased FC levels in gestational diabetes, while there is no study regarding carnitine levels in neonates born to diabetic mothers. Existing data raise questions regarding the impact of low carnitine levels observed in pregnancy on the intermediary metabolism of the mother and the offspring and the potential need for carnitine supplementation. The primary aim of this study was to investigate the carnitine shuttle system in nor-mal pregnancy and gestational diabetes as well as in the offspring, in parallel with the biochemical profile and the levels of total fatty acids and amino acids of the mother and the neonate in order to further explore whether 1. the low carnitine levels are involved in the changes of the fatty acids, carbohydrate and amino acid metabolism observed in normal pregnancy 2. these changes are exacerbated in well controlled gestational diabetes 3. the low maternal levels affect the neonatal carnitine levels 4. the potential changes in neonatal carnitine levels in normal and diabetic pregnancies are associated with altered intrauterine growth and/or intermediary metabolism of lipids, carbohydrates and amino acids in the newborn. The clarification of the role of the carnitine shuttle system in metabolic adaptation of pregnancy, diabetic and non-diabetic, could help make suggestions on the potential benefit and safety of L-carnitine supplementation to both pregnant women and neonates. To this aim, we assessed the levels of carnitine fractions in dried blood spots of diabetic and non-diabetic pregnant women and their neonates as well as in non-pregnant controls with comparable age which were subsequently related to the anthropometric and biochemical parameters and plasma levels of lipids and amino acids. [...]
Degree
thesis:*- Grantor dc:publisher
- Aristotle University Of Thessaloniki (AUTH)
- Year dc:date
- 2013
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Agakidou, Eleni
- Αγακίδου, Ελένη
Subjects
dc:subject × 20- Ακυλκαρνιτίνη
- Αμινοξέα
- β-οξείδωση
- Διαβήτης κύησης
- Διαδοχική φασματομετρία μάζας
- Λιπαρά οξέα
- Νεογνό διαβητικής μητέρας
- Acylcarnitine
- Aminoacids
- b-oxidation
- Gestational diabetes
- Tandem mass spectrometry
- Fatty acids
- Infant of diabetic mother
- Ιατρική και Επιστήμες Υγείας
- Βασική Ιατρική
- Κλινική Ιατρική
- Medical and Health Sciences
- Basic Medicine
- Clinical Medicine
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/31605